Label-free Array Systems Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence LLP||商品編碼||850264|
|出版日期||內容資訊||英文 114 Pages
|全球免標定陣列系統市場:成長，趨勢，預測 Label-free Array Systems Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年02月01日||內容資訊: 英文 114 Pages||
In recent years, label-free array systems have taken center stage as the research tool in many drug discovery processes. Label-free technologies are also used by manufacturers in context to patient samples, to produce biorelevant data that can result in effective drug development and precision medicine.
The global label-free array systems market is anticipated to witness a steady growth of approximately 6.2% CAGR during the forecast period, 2019-2024. As per the report, the global label-free array systems market was estimated to be worth USD 1245.11 million in 2018.
Modern medicine is moving toward precision or personalized medicine, to eliminate dosing redundancy in individuals. However, the biggest challenges in drug discovery and development are individual variability in drug effectiveness and a lack of translatability of pre-clinical results. Hence, companies are focusing on developing appropriate cellular models and readout systems to understand mechanisms and functional characterization on molecular and cellular levels. Moreover, next-gen label-free technologies, including mass spectrometers, biochips/microarrays, and others, have shown positive results in identifying clinical microorganisms. Companies are also developing micro plate-based optical biosensors that can be incorporated in the standard format microplates, to detect small molecules, cells, and proteins.
Biotechnology and pharmaceutical companies use label-free array systems in the drug discovery process. It works on the principle of refractive index, impedance-based assays, and optical interferometry, for identifying and validating new molecules as the possible drug candidates. The systems reduce the cost and time for drug identification and validation process.
As per the scope of this report, the global label-free array systems market is segmented by technology, application, end user, and geography.
The Surface Plasmon Resonance Technology Segment is Expected to the Exhibit the Fastest Growth During the Forecast Period
Based on the technology, the segmentation includes cellular dielectric spectroscopy, bio-layer interferometry, surface plasmon resonance, and other technologies. Among these, surface plasmon resonance technology is likely to experience significant growth in the global label-free array systems market.
North America Accounted for the Largest Share in the Global Market and is also the Fastest-growing Market
Region-wise, North America is expected to emerge as the leading region in the global label-free array systems market. The rise in chronic and life-threatening diseases is resulting in an increase in drug discovery programs in the United States. This is leading to increasing demand for label-free array systems in the region. The companies are also introducing label-free cell-based systems for early drug discovery. Meanwhile, certain issues, including a limit of detection and probability of the device, and the sensitivity of the device, are being optimized by manufacturers to offer better label-free array systems.
The global label-free array systems market is dominated by a few major players, and the global label-free array systems market is expected to experience growth, owing to the rising collaboration and partnerships between pharmaceutical and biotechnology companies, for expediting various drug discovery/designing processes.